v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue    
Total revenue $ 152,455 $ 25,427
Cost of revenues 242,325 0
Operating expenses    
Selling, general and administrative 2,248,566 2,309,164
Research and development 660,462 2,297,381
Total operating expenses 2,909,028 4,606,545
Loss from operations (2,998,898) (4,581,118)
Other (expense) income (991) 202,811
Net loss (2,999,889) (4,378,307)
Foreign currency translation adjustments 44,542 13,090
Comprehensive loss $ (2,955,347) $ (4,365,217)
Loss per common share - basic (in usd per share) $ (0.21) $ (0.50)
Loss per common share - diluted (in usd per share) $ (0.21) $ (0.50)
Weighted average number of shares outstanding:    
Basic (in shares) 14,522,835 8,759,053
Diluted (in shares) 14,522,835 8,759,053